Haojiang Dai

441 total citations
9 papers, 315 citations indexed

About

Haojiang Dai is a scholar working on Molecular Biology, Surgery and Oncology. According to data from OpenAlex, Haojiang Dai has authored 9 papers receiving a total of 315 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 3 papers in Surgery and 3 papers in Oncology. Recurrent topics in Haojiang Dai's work include RNA modifications and cancer (3 papers), Cancer-related Molecular Pathways (3 papers) and Ubiquitin and proteasome pathways (2 papers). Haojiang Dai is often cited by papers focused on RNA modifications and cancer (3 papers), Cancer-related Molecular Pathways (3 papers) and Ubiquitin and proteasome pathways (2 papers). Haojiang Dai collaborates with scholars based in China, Madagascar and Canada. Haojiang Dai's co-authors include Shusen Zheng, Xiao Xu, Haiyang Xie, Qiaonan Shan, Penghong Song, Sunbin Ling, Jie Li, Lin Zhou, Zhikun Liu and Jun Chen and has published in prestigious journals such as Scientific Reports, Journal of Hematology & Oncology and BMC Cancer.

In The Last Decade

Haojiang Dai

9 papers receiving 313 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Haojiang Dai China 7 207 74 72 50 47 9 315
Kailiang Zhao China 10 182 0.9× 73 1.0× 117 1.6× 31 0.6× 54 1.1× 38 354
Michalis E. Sarris Greece 7 220 1.1× 57 0.8× 92 1.3× 43 0.9× 36 0.8× 7 344
Guo‐Qing Tao China 10 164 0.8× 62 0.8× 167 2.3× 40 0.8× 28 0.6× 19 333
Xufeng Lu China 8 151 0.7× 68 0.9× 47 0.7× 41 0.8× 44 0.9× 15 329
Zhen Zhu China 12 268 1.3× 124 1.7× 113 1.6× 97 1.9× 70 1.5× 23 464
Kenly Wuputra Taiwan 11 256 1.2× 82 1.1× 84 1.2× 37 0.7× 17 0.4× 27 378
Nanhong Tang China 11 211 1.0× 173 2.3× 102 1.4× 68 1.4× 40 0.9× 18 391
Yunfei Duan China 12 198 1.0× 149 2.0× 49 0.7× 54 1.1× 53 1.1× 17 350
Siyu Tan China 13 262 1.3× 103 1.4× 154 2.1× 31 0.6× 55 1.2× 29 548

Countries citing papers authored by Haojiang Dai

Since Specialization
Citations

This map shows the geographic impact of Haojiang Dai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haojiang Dai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haojiang Dai more than expected).

Fields of papers citing papers by Haojiang Dai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Haojiang Dai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haojiang Dai. The network helps show where Haojiang Dai may publish in the future.

Co-authorship network of co-authors of Haojiang Dai

This figure shows the co-authorship network connecting the top 25 collaborators of Haojiang Dai. A scholar is included among the top collaborators of Haojiang Dai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Haojiang Dai. Haojiang Dai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Qiu, Qiongzi, Wenfeng Song, Shiyu Zhang, et al.. (2025). Comprehensive multi-omics analyses expose a precision therapy strategy that targets replication stress in hepatocellular carcinoma using WEE1 inhibition. Journal of Advanced Research. 78. 497–515. 2 indexed citations
2.
Zhang, Shiyu, Haojiang Dai, Wenfeng Song, et al.. (2024). SERPINE2 promotes liver cancer metastasis by inhibiting c‐Cbl‐mediated EGFR ubiquitination and degradation. Cancer Communications. 44(3). 384–407. 22 indexed citations
3.
Liu, Qingjiang, Wei Ling, Haojiang Dai, et al.. (2022). Porous Electrode Materials for Zn-Ion Batteries: From Fabrication and Electrochemical Application. Batteries. 8(11). 223–223. 6 indexed citations
4.
Fang, Zheping, Haojiang Dai, Peng Hu, et al.. (2020). The role of vesicular overexpressed in cancer pro-survival protein 1 in hepatocellular carcinoma proliferation. Cancer Biomarkers. 28(1). 9–20. 6 indexed citations
5.
Liu, Zhikun, Jie Li, Jun Chen, et al.. (2018). MCM family in HCC: MCM6 indicates adverse tumor features and poor outcomes and promotes S/G2 cell cycle progression. BMC Cancer. 18(1). 200–200. 99 indexed citations
6.
Ling, Sunbin, Jie Li, Qiaonan Shan, et al.. (2017). USP22 mediates the multidrug resistance of hepatocellular carcinoma via the SIRT1/AKT/MRP1 signaling pathway. Molecular Oncology. 11(6). 682–695. 84 indexed citations
7.
Ling, Qi, Haojiang Dai, Runzhou Zhuang, et al.. (2017). Predicting short-term survival after liver transplantation on eight score systems: a national report from China Liver Transplant Registry. Scientific Reports. 7(1). 42253–42253. 16 indexed citations
8.
Ling, Sunbin, Haiyang Xie, Fan Yang, et al.. (2017). Metformin potentiates the effect of arsenic trioxide suppressing intrahepatic cholangiocarcinoma: roles of p38 MAPK, ERK3, and mTORC1. Journal of Hematology & Oncology. 10(1). 59–59. 61 indexed citations
9.
Liu, Yu-Hui, Xuyong Wei, Kun Wang, et al.. (2016). Enucleation versus Anatomic Resection for Giant Hepatic Hemangioma: A Meta-Analysis. PubMed. 3(3-4). 153–162. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026